How do I find out if I qualify for a hormone receptor positive breast carcinoma study in New York?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in New York to take part?

Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a hormone receptor positive breast carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · New York

Hormone Receptor Positive Breast Carcinoma clinical trials in New York

We’re tracking 27 recruiting hormone receptor positive breast carcinoma studies with a site in New York — including Phase 1 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in New York

NCT07213791RecruitingPhase 1
Study of a new drug for FAP-positive cancers
This trial tests a new drug (LY4337713) for cancers that have a specific protein called FAP on their surface. It may be an option for people whose cancer has continued to grow after standard treatments.
New York, New YorkAges 18 years+
NCT05983432RecruitingPhase 1
Study of BL-B01D1 for advanced lung and other solid tumors
This trial tests an experimental drug called BL-B01D1 for people with several types of advanced solid tumors, especially non-small cell lung cancer and breast cancer. It's designed for those whose cancer has continued to grow after standard treatments.
New York, New YorkAges 18 years+
NCT06172478RecruitingPhase 2
HER3-DXd for advanced solid tumors after prior treatment
This trial tests a new targeted drug called HER3-DXd for people with several types of advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate, designed to deliver chemotherapy directly to cancer cells that have a protein called HER3 on their surface.
Buffalo, New YorkAges 18 years+

Hormone Receptor Positive Breast Carcinoma trials by city in New York

New York

Where these studies are running in New York

Institutions with a site for the recruiting hormone receptor positive breast carcinoma studies listed above.

Memorial Sloan Kettering Cancer Center · 2 studies
Memorial Sloan Kettering Cancer Center Head Neck Services
New York University (NYU) Clinical Cancer Center
Roswell Park Comprehensive Cancer Center

What taking part in a hormone receptor positive breast carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Hormone Receptor Positive Breast Carcinoma trials in other states

Common questions

Are there hormone receptor positive breast carcinoma clinical trials in New York?: Yes. We're currently tracking 27 recruiting hormone receptor positive breast carcinoma studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a hormone receptor positive breast carcinoma study in New York?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in New York to take part?: Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a hormone receptor positive breast carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New hormone receptor positive breast carcinoma studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.